Edition:
United States

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

3.92USD
1:18pm EDT
Change (% chg)

$-0.12 (-2.97%)
Prev Close
$4.04
Open
$4.01
Day's High
$4.02
Day's Low
$3.88
Volume
10,759
Avg. Vol
58,157
52-wk High
$18.15
52-wk Low
$2.63

Latest Key Developments (Source: Significant Developments)

Biossance says will expand to Sephora in over 60 Sephora locations across Canada
Wednesday, 26 Jul 2017 08:30am EDT 

July 26 (Reuters) - Amyris Inc ;:Biossance says will expand to Sephora in over 60 Sephora locations across Canada in January 2018.  Full Article

Amyris enters into first product development, production agreement with Royal DSM
Monday, 17 Jul 2017 08:50am EDT 

July 17 (Reuters) - Amyris Inc ::Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule.Amyris Inc - ‍as part of agreement, DSM will partner with co, fund development of technology to produce specific molecule that co will scale, supply​.  Full Article

Amyris, on June 30, 2017, company issued, sold an amended, restated note in principal amount of $3 mln to purchaser
Friday, 7 Jul 2017 05:05pm EDT 

July 7 (Reuters) - Amyris Inc ::Amyris Inc - on June 30, 2017, company issued and sold an amended and restated note in principal amount of $3.0 million to purchaser - sec filing.Amyris Inc - in connection with issuance and sale of $3 million note, company and purchaser entered into a letter agreement.Amyris Inc - pursuant to letter agreement, purchaser has right to cause coto redeem all of outstanding principal amount of $3 million note in cash.Amyris Inc - pursuant to letter agreement purchaser has right to cause company to redeem all of outstanding principal amount of $3 million note in cash.  Full Article

Amyris and government of Queensland announced plans to develop a industrial biotechnology hub in Southeast Asia
Tuesday, 20 Jun 2017 08:30am EDT 

June 20 (Reuters) - Amyris Inc :Amyris Inc and government of Queensland, Australia announced plans to develop a industrial biotechnology hub in Southeast Asia.  Full Article

Amyris announces reverse stock split
Tuesday, 6 Jun 2017 08:00am EDT 

June 6 (Reuters) - Amyris Inc :Amyris announces reverse stock split - delivering on strong product revenue growth and execution.Amyris Inc- every 15 pre-split shares of common stock held by stockholders will automatically be converted into one share of common stock.Amyris Inc - co's common stock will begin trading on a split-adjusted basis as of commencement of trading on june 6, 2017.  Full Article

Amyris reports Q1 loss per share of $0.13
Monday, 15 May 2017 04:22pm EDT 

May 15 (Reuters) - Amyris Inc :Amyris reports 164 pct product revenue growth over prior year & continued strong outlook.Q1 loss per share $0.13.Q1 revenue rose 47 percent to $13 million.Q1 revenue view $32.3 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S."Expect to deliver around $60 million of product revenue for 2017"."Significant" progress in healthy sweeteners with expected commercial production in 2018 of low cost.Sees FY total revenue to be "better than" 2017 plan.Expects growing farnesene for vitamin E oil from around $6 million in 2016 to around $20 million in 2017.Expect to deliver around $60 million of product revenue for 2017, or more than double from 2016.  Full Article

DSM to make equity investment in Amyris
Monday, 8 May 2017 08:41am EDT 

May 8 (Reuters) - DSM ::ROYAL DSM TO MAKE EQUITY INVESTMENT IN AMYRIS <<>> WITH THE PURPOSE OF ESTABLISHING A LONG-TERM RELATIONSHIP.AGREED TO MAKE AN INITIAL EQUITY INVESTMENT IN AMYRIS OF US$25 MILLION, TRANSLATING INTO A SHAREHOLDING OF ABOUT 12 PCT.SUBJECT TO THE SATISFACTION OF CERTAIN CONDITIONS, DSM MAY INVEST AN ADDITIONAL US$25 MILLION IN AMYRIS.FIRST TRANCHE IS EXPECTED TO CLOSE ON MAY 11 2017, WITH SECOND TRANCHE, IF APPROVED BY DSM’S MANAGING BOARD, EXPECTED TO CLOSE WITHIN 90 DAYS OF CLOSING OF FIRST TRANCHE.  Full Article

Amyris says entered into securities purchase agreement with certain investors
Monday, 8 May 2017 08:34am EDT 

May 8 (Reuters) - Amyris Inc :Amyris inc - on may 8, 2017, amyris, inc. Entered into a securities purchase agreement with certain investors - sec filing.Amyris inc expects net proceeds from sale of securities to be about $44.5 million.Amyris inc - intends to use about $9.5 million of net proceeds from offering for redemption of convertible notes issued by co in dec 2016 and april 2017.Amyris inc says to sell 22,140 shares of co's s series a 17.38% convertible preferred stock, about 65,203 shares of co's series b 17.38% convertible preferred stock.  Full Article

Amyris announces agreements for up to $95 mln in equity financing
Monday, 8 May 2017 08:30am EDT 

May 8 (Reuters) - Amyris Inc :Amyris announces agreements for up to $95 million in equity financing and in-process initiative to significantly reduce debt.Equity financing commitment includes participation by Koninklijke DSM N.V., DSM agreed to initial equity investment in Co of $25 million.Subject to satisfaction of certain conditions, DSM may invest an additional $25 million in Amyris.Is in process of reducing its debt by about $75 million, about $40 million of such amount is being converted pursuant to terms of equity financing.  Full Article

Amyris makes develomental progress in its healthy sweetener product technology
Monday, 1 May 2017 08:00am EDT 

May 1 (Reuters) - Amyris Inc -:Amyris Inc - made significant progress in development of its healthy sweetener product technology and expects industrial production to occur in 2018.Expects sweetener product opportunity in partnership with its partner to deliver over $100 million in annual revenue by 2020.  Full Article

BRIEF-Amyris enters into first product development, production agreement with Royal DSM

* Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule